Fulgent Genetics Stock Target Price and Analyst Consensus
| FLGT Stock | USD 20.64 0.08 0.39% |
The current analyst and expert consensus on Fulgent Genetics is Buy, with no strong buy opinions. The current projected Fulgent Genetics target price consensus is 36.50 with 3 analyst opinions. The most common way Fulgent Genetics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Fulgent Genetics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Fulgent Genetics. We encourage you to use your own analysis of Fulgent Genetics to validate this buy or sell advice. Fulgent Genetics buy-or-sell recommendation module provides average expert sentiment on the projected Fulgent Genetics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Fulgent Genetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.
Lowest Forecast 33.22 | Highest Forecast 40.52 | Target Price 36.5 |
Fulgent |
It's important to approach Fulgent Genetics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Fulgent Genetics price targets
Fulgent Genetics' stock target price is an estimate of its future price, usually made by analysts. Using Fulgent Genetics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Fulgent Genetics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Fulgent Genetics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Fulgent Genetics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Fulgent Genetics is a key component of Fulgent Genetics valuation and have some predictive power on the future returns of a Fulgent Genetics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fulgent Genetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cash Cows Invested a lot of shares | |
 | Manufacturing Invested over 40 shares | |
 | Baby Boomer Prospects Invested over 50 shares | |
 | Momentum Invested few shares | |
 | Dividend Beast Invested over 70 shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Driverless Cars Invested over 200 shares | |
Check out Macroaxis Advice on Fulgent Genetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.Note that the Fulgent Genetics information on this page should be used as a complementary analysis to other Fulgent Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Fulgent Stock analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets |
The data published in Fulgent Genetics' official financial statements usually reflect Fulgent Genetics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Fulgent Genetics. For example, before you start analyzing numbers published by Fulgent accountants, it's critical to develop an understanding of what Fulgent Genetics' liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Fulgent Genetics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Fulgent Genetics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Fulgent Genetics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Fulgent Genetics. Please utilize our Beneish M Score to check the likelihood of Fulgent Genetics' management manipulating its earnings.